| Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia S Gudbrandsdottir, HS Birgens, H Frederiksen, BA Jensen, MK Jensen, ... Blood, The Journal of the American Society of Hematology 121 (11), 1976-1981, 2013 | 197 | 2013 |
| Activated platelets enhance IL-10 secretion and reduce TNF-α secretion by monocytes S Gudbrandsdottir, HC Hasselbalch, CH Nielsen The Journal of Immunology 191 (8), 4059-4067, 2013 | 135 | 2013 |
| TNF and LT binding capacities in the plasma of arthritis patients: effect of etanercept treatment in juvenile idiopathic arthritis. S Gudbrandsdottir, R Larsen, LK Sørensen, S Nielsen, MB Hansen, ... Clinical and experimental rheumatology 22 (1), 118-124, 2004 | 43 | 2004 |
| First-line therapy for immune thrombocytopenia S Mithoowani, DM Arnold Hämostaseologie 39 (03), 259-265, 2019 | 42 | 2019 |
| Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents W Ghanima, P Junker, HC Hasselbalch, L Boiocchi, JT Geyer, X Feng, ... British journal of haematology 155 (2), 248-255, 2011 | 42 | 2011 |
| Thrombopoietin-receptor agonists in haematological disorders: the Danish experience S Gudbrandsdottir, H Frederiksen, H Hasselbalch Platelets 23 (6), 423-429, 2012 | 25 | 2012 |
| Effects of rituximab and dexamethasone on regulatory and proinflammatory B‐cell subsets in patients with primary immune thrombocytopenia S Gudbrandsdottir, M Brimnes, T Køllgaard, HC Hasselbalch, CH Nielsen European journal of haematology 100 (1), 45-52, 2018 | 21 | 2018 |
| Combination of thrombopoietin receptor agonists, immunosuppressants and intravenous immunoglobulin as treatment of severe refractory immune thrombocytopenia in adults and children. S Gudbrandsdottir, E Leven, A Imahiyerobo, CS Lee, J Bussel British Journal of Haematology 189 (2), 2020 | 17 | 2020 |
| Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP) S Gudbrandsdottir, W Ghanima, CH Nielsen, X Feng, HC Hasselbalch, ... Platelets 28 (5), 478-483, 2017 | 17 | 2017 |
| A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs? DN LeVine, AJ Birkenheuer, MB Brooks, SK Nordone, DA Bellinger, ... British journal of haematology 167 (1), 110-120, 2014 | 15 | 2014 |
| Plasma TNF binding capacity profiles during treatment with etanercept in rheumatoid arthritis S Gudbrandsdottir, H Bliddal, A Petri, L Terslev, B Danneskiold-Samsoe, ... Scandinavian journal of rheumatology 33 (6), 385-388, 2004 | 15 | 2004 |
| Ruxolitinib treatment reduces monocytic superoxide radical formation without affecting hydrogen peroxide formation or systemic oxidative nucleoside damage in myelofibrosis ME Bjørn, MK Brimnes, S Gudbrandsdottir, CL Andersen, HE Poulsen, ... Leukemia & Lymphoma, 2019 | 9 | 2019 |
| Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based … T Trab, J Baech, LH Jakobsen, S Husby, MT Severinsen, S Eloranta, ... The Lancet Haematology 10 (10), e838-e848, 2023 | 6 | 2023 |
| Plasma TNF binding capacity in patients with juvenile idiopathic arthritis B Bjørnhart, P Svenningsen, S Gudbrandsdottir, M Zak, S Nielsen, ... International immunopharmacology 5 (1), 73-77, 2005 | 5 | 2005 |
| Correlation between free serum etanercept levels and clinical response to treatment in RA. RF van Vollenhoven, S Gudbrandsdottir, T Jonsdottir, K Muller, ... ARTHRITIS AND RHEUMATISM 52 (9), S134-S134, 2005 | 4 | 2005 |
| Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on … W Ghanima, L Boiocchi, CS Lee, X Feng, JT Geyer, S Gudbrandsdottir, ... Platelets 30 (2), 222-228, 2019 | 3 | 2019 |
| The pathogenesis of primary immune thrombocytopenia S Gudbrandsdottir, H Frederiksen, HS Birgens, CH Nielsen, OJ Nielsen, ... Ugeskrift For Laeger 173 (4), 274-277, 2011 | 2 | 2011 |
| New treatment options for primary immune thrombocytopenia S Gudbrandsdottir, H Frederiksen, HS Birgens, CH Nielsen, OJ Nielsen, ... Ugeskrift for Laeger 173 (4), 271-274, 2011 | 2 | 2011 |
| Efficacy of Rituximab in combination with Dexamethasone vs Dexamethasone in newly diagnosed patients with primary immune thrombocytopenia-an interim analysis of a prospective … S Gudbrandsdottir, H Frederiksen, IH Rasmussen, B Jensen, L Kjeldsen, ... | 2 | 2010 |
| Cardiovascular diseases after high‐dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population‐based study J Baech, S Husby, T Trab, K Kragholm, P Brown, JS Gørløv, ... British Journal of Haematology 204 (3), 967-975, 2024 | 1 | 2024 |
